An Incisive, In-depth Analysis on the Dna Polymerase Market
This study offers a comprehensive, 360 degree analysis on the Dna Polymerase market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Dna Polymerase market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Increased Spending on Biopharmaceutical Research and Development
There has been a shift from investment in research and development activities in life sciences and biotechnology in Asia Pacific. Contract research organizations operating in the region are working on various generic biologics development. Upcoming patent expiration of branded pharmaceuticals and success in ongoing clinical trial activities are booting the commercial use of molecular-based techniques. Additionally, government authorities are taking initiatives to reduce drugs cost, which has provided ground-breaking support for the growth of the domestic biotechnology and pharmaceutical market. Government authorities are offering tax benefits for R&D activities, increased budgets and funding, creating public and private conglomerates and attracting foreign direct investments.
Availability of Alternate Technologies with Low DNA Requirement
Techniques such as PCR require nucleic acids in sufficient quantity and purity for processing using various applications. Various techniques have been recently developed that are able to detect ultra-low quantities of DNA with minimal processing, and are also able to process short nucleotide sequences such as microRNA. Scientists at the Seoul National University in South Korea published results in 2017 from experiments using gold nanoparticles covered with DNA sequences that bind to, and detect the DNA of interest using dark-field microscopy. Such innovative methods bypass the need for DNA amplification and thus the requirement of DNA polymerase.
Emergence of E-commerce-based Distribution Channels
Certain products are currently ordered online or via eProcurement while some requests need assistance from the sales and product teams. Customers using DNA polymerase and associated reagents and tools tend to be highly educated, content-driven and adopt new technology leading to a shift in the way they procure these products. Depending on the market strategy of vendors in this market and their willingness to invest, they have the opportunity to increase their revenue and gain market share from distributors.
Development of DNA Polymerase to be Used in Multiple Applications
Manufacturers of DNA polymerase have developed several products that have the ability to be used in both research applications as well as for clinical diagnostics. Most of the commercially available polymerase are either suitable for PCR amplification (research use) or isothermal amplification (point-of-care clinical diagnostics use), not both. These DNA polymerase are typically mutant versions of traditional Taq DNA polymerase that combine the thermostability of Taq with strand displacement activity of other enzymes, which are critical in isothermal techniques
In-house Development of DNA Polymerases
Several end-use segments prefer to develop DNA polymerase in-house due to certain protocols and specifications, as a result of which the commercial sales of DNA polymerase to these users are limited. Additional reasons to produce DNA polymerase in-house could be due to cost constraints, ease of manufacturing and limited requirements, as well as non-availability of specific features in commercially sold DNA polymerase required for the study being carried out. As various key players seek to expand their product portfolio by incorporating different features such as hot-start, it is likely that specific requirements can be met through commercially available DNA polymerase.
The competition section highlights the profiles of leading companies operating in the DNA polymerase market based on their company market shares, key product offerings, channel strategies, marketing initiatives, product reach and competition dashboard. Examples of some of the key players profiled in the report are Thermo Fisher Scientific Inc., Agilent Technologies Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., Takara Bio Inc., Genescript, Illumina Inc., New England Biolabs, Inc., and Bioline & Promega Corporation.
Point-of-care molecular diagnostic in clinical, forensics and food industries has spurred the demand for reliable and accurate testing technique. Manufacturers of POCT testing devices are primary focusing on launching easy-to-use PCR and sequencing platform for rapid detection. In 2015, the FDA granted the first CLIA waiver to Alere for its influenza nucleic acid-based test, followed by Roche for its cobas systems. Several hospitals and clinics are likely to adopt point-of-care molecular diagnostics based on PCR technologies, especially considering their high sensitivity to seasonal influenza strains.
Consolidations activities, such as sales and service agreements, collaborations, rising research and development activities, new product launches, joint ventures, partnerships, patent transfers and mergers & acquisitions among the global and regional players are a characteristic phenomenon of the overall competition in the PCR equipment and reagents market. Many global players have set up new manufacturing facilities and distribution agreements in countries such as Brazil and Mexico to increase their product reach.
Request Information on Competitive Landscape
The DNA polymerases are enzymes that are responsible for creating new copies of DNA in the form of nucleotides, which are building blocks of DNA. DNA polymerase duplicates all of its DNA strands and the cell passes one copy of each strand to its daughter cell. DNA polymerase is used to create an extra copy of DNA each time the cell divides making less than one mistake in a billion bases. DNA polymerase is used to “proofread” the original DNA strand so that the misplaced base are corrected. There are two types of DNA polymerase, namely Prokaryotic DNA Polymerase and Eukaryotic DNA Polymerase.
About the Report
FMI conducted a research study on DNA polymerase market for the forecast period of 2017 to 2027. The report offers a comprehensive evaluation of the business opportunities prevailing in the DNA polymerase market along with insights on the competition strategies, consumer adoption. The report also covers comprehensive attributes of multi-application DNA polymerase and pricing analysis, company penetration and market competition. The report elaborates on the macro factors influencing the DNA polymerase market.
The report offers a comprehensive taxonomy of the DNA polymerase market based on product type, end users, and regions. Based on product type, the DNA polymerase market is segmented into Prokaryotic DNA Polymerase & Eukaryotic DNA Polymerase. The end-use segment of the report covers Molecular Diagnostics Companies, Diagnostic Laboratories, Academic and Research Institutes, Biopharmaceutical Companies & Hospitals. The DNA polymerase market has been analysed across regions of North America, Eastern Europe, Western Europe, Latin America, Asia Pacific Excluding Japan, Japan, Middle East and Africa.
Additional Questions Answered
Some of the additional questions addressed in the report for DNA polymerase market-
What is role of regulatory authority and service providers in market?
What is the revenue potential of DNA polymerase across pharmaceutical research and diagnostic applications?
How DNA polymerase market is gaining momentum in Asia region?
Who are the key competitors and what are their portfolios in DNA polymerase market?
What is the price point for DNA polymerase manufacturers in developed countries?
The report on DNA polymerase market has been carefully compiled post a rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The report on DNA polymerase market also embodies an overall qualitative and quantitative assessment by scrutinizing data points garnered from market participants of DNA polymerase market. The research study on DNA polymerase market also includes top trends and macro as well as micro economic factors shaping the DNA polymerase market. With this approach, the report on DNA polymerase market anticipates the industry attractiveness of every major segment over the forecast timespan.
A recent market study published by FMI – DNA polymerase Market: Global Industry Analysis & Opportunity Assessment, 2017 – 2027 – consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of DNA polymerase market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may impact the development of the DNA polymerase market during the forecast period. It can help the market players to modify their manufacturing and marketing strategies to envisage maximum growth in the DNA polymerase market in the upcoming years. The report provides detailed information about the current and future growth prospects of the DNA polymerase market in the most comprehensive way for the better understanding of readers.
Chapter 01 – Executive Summary
The report commences with the executive summary of the DNA polymerase market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the DNA polymerase market.
Chapter 02 – Market Introduction
Readers can find detailed taxonomy and the definition of the DNA polymerase market in this chapter, which will help the readers to understand the basic information about the DNA polymerase market.
Chapter 03 – Market View Point
Readers can find comprehensive information regarding the key market drivers & restraints along with recent illustrations of the DNA polymerase market. In this chapter, the readers will gain insights on regulatory landscape and trends associated with the DNA polymerase market. The chapter also highlights regional level pricing analysis of DNA polymerase solution in various regions.
Chapter 04 – North America DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
This chapter includes a detailed analysis of the growth of the North America DNA polymerase market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, and market growth based on product type, end users, and countries in the North America DNA polymerase market.
Chapter 05 – Latin America DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
Readers can find detailed information about factors such as pricing analysis, and market dynamics that are impacting the growth of the Latin America DNA polymerase market. This chapter also includes the growth prospects of the DNA polymerase market in leading LATAM countries such as Brazil, Mexico, and Rest of the Latin America region.
Chapter 06 – Western Europe DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
Important growth prospects of the DNA polymerase market based on its product type, and end users in several European countries, such as Germany, France, Italy, Spain, the U.K., BENELUX, and Rest of Western Europe are included in this chapter.
Chapter 07 – Eastern Europe DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
Important growth prospects of the DNA polymerase market based on its product type, end user, pathology screening services in several European countries, such as Russia, Poland, and Rest of Eastern Europe are included in this chapter.
Chapter 08 – APEJ DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
China, India, ASEAN, Australia and New Zealand are the leading countries in the APEJ region that are the prime subject of assessment to obtain growth prospects of the APEJ DNA polymerase market in this chapter. Readers can find thorough information about the growth parameters of the APEJ DNA polymerase market during the period 2017 – 2027.
Chapter 09 – Japan DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
Readers can find important factors that may impact the growth of the DNA polymerase market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the Japan DNA polymerase market.
Chapter 10 – MEA DNA Polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
This chapter provides information on how the DNA polymerase market will grow in the major countries in MEA region, such as GCC Countries, and South Africa during the period 2017 – 2027.
Chapter 11 & 12 – MEA DNA polymerase Market Analysis & Opportunity Assessment, 2017 – 2027
This chapter provides information on impact of various forecasting factors & assumptions considered during the study. Readers will get a detailed information on list of factors considered during forecasting of the DNA polymerase market.
Chapter 13 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the DNA polymerase market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. The players featured in the report include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., Agilent Technologies Inc., Takara Bio Inc., Genescript, Illumina Inc., New England Biolabs, Inc., and Bioline & Promega Corporation.
Chapter 14 – Global DNA polymerase Market Analysis & Opportunity Assessment, 2017 – 2027, By Region
This chapter explains how the DNA polymerase market will grow across various geographic regions, such as North America, Asia-Pacific Excluding Japan (APEJ), Japan, Western Europe, Latin America, Eastern Europe, and the Middle East & Africa (MEA).
Chapter 15 – Global DNA polymerase Market Analysis & Opportunity Assessment 2017 – 2027, By Product Type
Based on the product type, the DNA polymerase market is segmented into Prokaryotic DNA Polymerase & Eukaryotic DNA Polymerase. In this chapter, the readers can find information about the key trends and developments in the DNA polymerase market and market attractive analysis based on the type of DNA polymerase. In this chapter, readers can find information about the key trends and developments in the DNA polymerase market and market attractive analysis based on the product type for each region.
Chapter 16 – Global DNA polymerase Market Analysis & Opportunity Assessment, 2017 – 2027, By End Users
Based on the end users, the DNA polymerase market is segmented into Molecular Diagnostics Companies, Diagnostic Laboratories, Academic and Research Institutes, Biopharmaceutical Companies, & Hospitals. In this chapter, readers can find information about the key trends and developments in the DNA polymerase market and market attractive analysis based on the end users.
Chapter 18 & 19 – Research Methodology
The chapter covers an overview of research methodology followed to estimate the regional level market value of the DNA polymerase market. The chapter also highlights the list of assumptions and acronyms used during the report. This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the DNA polymerase market.